Toprol-XL: Uses, Dosage & Safety Information

Toprol-XL

Toprol-XL

Toprol-XL

Metoprolol
Extended-release beta-blocker brand cleared in 1992, taken once daily for raised readings from age six, chest pain and weak-heart failure. It cut deaths by a third in a major heart-failure trial, scored doses may be halved but never crushed, and it must be tapered rather than stopped.
  • ActiveIngredient: Metoprolol
  • DosageForm: Extended-release tablet
  • Dosage: 25 mg, 50 mg, 100 mg, 200 mg
  • Indications: Hypertension, angina pectoris, heart failure
  • Manufacturer: Melinta Therapeutics
  • Storage: 25°C (77°F)
  • Drug Status: Prescription Only

What is Toprol-XL?

Toprol-XL is the extended-release brand of metoprolol succinate, a beta-1-selective beta-blocker approved for high blood pressure in adults and children aged 6 or older, for angina, and for stable heart failure with reduced ejection fraction to reduce cardiovascular death and heart-failure admissions. In MERIT-HF it lowered all-cause mortality by 34% in heart failure. It is a different salt and formulation from immediate-release metoprolol tartrate (Lopressor), although switching uses the same total daily dose.1

FDA-approved brand, prescription only
Toprol-XL (NDA 019962) was approved in January 1992 and remains a prescription brand, now marketed by Melinta Therapeutics.2

Approved products and generic therapeutic-equivalence ratings are listed in the FDA Orange Book.3

Metoprolol blocks mainly beta-1 receptors in the heart; the extended-release tablet produces beta-1 blockade similar to conventional metoprolol tablets taken in divided doses through the day.1

Because blood levels vary between people and do not track the blood-pressure effect closely, the dose is found by individual titration.1

The tablets are white, film-coated and scored, engraved A with a code for each strength, so they can be divided but should not be crushed or chewed.

Metoprolol is broken down by CYP2D6, so inhibitors of that enzyme are likely to raise its levels.

People taking a beta-blocker may not respond to the usual doses of epinephrine used to treat a severe allergic reaction, which matters for anyone with a history of anaphylaxis.

Toprol-XL belongs to the blood pressure medicines; carvedilol and nebivolol are other beta-blockers used in cardiovascular care.

How to Take Toprol-XL

Once a day

Take Toprol-XL once a day; dose changes are made at weekly or longer intervals.1

Splitting, not crushing

The scored tablets may be divided in half, but the whole or half tablet should be swallowed without crushing or chewing.

Switching from metoprolol tartrate

If you change from immediate-release metoprolol, the same total daily dose is used once a day.

Heart failure start

In heart failure, treatment starts at a low dose and is doubled every two weeks as tolerated; early difficulties do not rule out later attempts.

Never stop suddenly

Stopping is done gradually over one to two weeks, even if you take it only for blood pressure.

If you have diabetes

Metoprolol may increase the risk of low blood sugar and hide its early warning signs, such as a fast heartbeat; check your sugar as advised.

Allergy emergencies

If you carry epinephrine for severe allergies, tell your doctor: people on beta-blockers may not respond to the usual dose.

What Are the Side Effects of Toprol-XL?

In hypertension and angina, most side effects were mild and transient; in MERIT-HF, fewer patients stopped Toprol-XL for side effects than stopped placebo.

Toprol-XL in MERIT-HF: AEs
FrequencyEffectNotes
Common — 1.8% (placebo 1.0%)Dizziness or vertigoMERIT-HF
Common — 1.5% (placebo 0.4%)Slow heart rateMERIT-HF
Common — 10.3% (placebo 12.2%)Stopped treatment because of side effectsMERIT-HF
Common — more than 2%Tiredness, dizziness, depression, diarrhoea, breathlessness, slow heart rate, rashHypertension and angina trials
Frequency not established (labelled)Worsening angina, heart failure or heart blockWarnings

Source: 1

Seek immediate medical attention if:
  • A very slow pulse, fainting or severe dizziness
  • Wheezing or difficulty breathing
  • Chest pain after stopping or missing doses
  • Rapid weight gain, swelling or breathlessness
Clinical details

In heart failure, transient worsening of symptoms during up-titration is managed with diuretics or by lowering the dose, and symptomatic slow heart rate calls for a dose reduction.

What is Toprol-XL Used For?

Toprol-XL is indicated for high blood pressure, for angina pectoris, and for stable symptomatic heart failure with reduced ejection fraction of ischaemic, hypertensive or cardiomyopathic origin, to reduce cardiovascular death and heart-failure hospitalisation.1

Heart failure (MERIT-HF)

MERIT-HF randomised 3,991 people with an ejection fraction of 40% or less and NYHA class II–IV symptoms, almost all on diuretics and ACE inhibitors. It was stopped early after a mean of one year because Toprol-XL reduced all-cause mortality by 34% and the combination of death or any hospitalisation by 19%; the dose was titrated as tolerated toward the labelled maximum.1

Blood pressure

In a study of 1,092 people with mild-to-moderate hypertension, Toprol-XL alone lowered sitting blood pressure by 6–8/4–7 mmHg more than placebo at 24 hours after the dose, and adding extended-release felodipine lowered it further.1

Angina

Immediate-release metoprolol reduced angina attacks and increased exercise tolerance in controlled trials, and Toprol-XL given once daily has been shown to control angina similarly; the dose is raised weekly until the optimal response or a marked slowing of the pulse.1

Surgery

High-dose extended-release metoprolol should not be started in people about to have non-cardiac surgery, but long-term treatment is not routinely stopped beforehand.

Children

In 144 children aged 6 to 16, the study missed its primary dose-response endpoint, though some secondary endpoints showed effectiveness; it has not been studied under age 6.

Interactions Alcohol:

Consult your doctor
Alcohol is not addressed in the Toprol-XL labelling; since both lower blood pressure, check with your doctor.

Interactions Other Medications:

Use with caution
CYP2D6 inhibitors, clonidine, digitalis, diltiazem, verapamil and reserpine interact; see Interactions.

Special Groups Pregnancy:

Consult your doctor
Observational data have not shown a clear risk, though growth restriction and preterm birth have been inconsistently reported.

Special Groups Breastfeeding:

Use with caution
Metoprolol is present in human milk at about 0.5–2% of the maternal dose; monitor the infant.

Special Groups Elderly:

Use with caution
Start at the low end of the dose range and titrate carefully.

Special Groups Children:

Use with caution
Studied for blood pressure from age 6 at weight-based doses; not studied under 6.

Effects on Activities Driving:

Use with caution
Tiredness or dizziness can occur; see how you react before driving.

Effects on Activities Operating Machinery:

Use with caution
Do not operate dangerous machinery while you feel faint or tired.

Survival benefit in heart failure

MERIT-HF was stopped early because Toprol-XL cut all-cause mortality by 34%, with consistent effects across subgroups, although the labelling cautions that subgroup analyses can be hard to interpret.1

Succinate versus tartrate

Toprol-XL is an extended-release succinate tablet taken once daily, whereas metoprolol tartrate is immediate release; when switching, the same total daily dose is used.

Generic metoprolol succinate

Generic extended-release metoprolol succinate must contain the same active ingredient and be bioequivalent to Toprol-XL.4

Where it comes from

Toprol-XL is prescription-only in the US; the FDA’s BeSafeRx guidance lists four signs of a lawful pharmacy website.5

Critical Warnings for Toprol-XL Use

Contraindications

Toprol-XL is contraindicated in severe bradycardia, second- or third-degree heart block, cardiogenic shock, decompensated heart failure, sick sinus syndrome without a pacemaker and hypersensitivity to its components.1

Abrupt cessation

Angina has worsened and heart attacks have occurred after abrupt withdrawal of some beta-blockers, so Toprol-XL is reduced over one to two weeks, even in people treated only for blood pressure.

Heart failure

Heart failure can worsen during up-titration; diuretics are increased and the dose is not raised until symptoms are stable.

Lungs and circulation

Beta-blockers are generally avoided in bronchospastic disease, and they can aggravate peripheral arterial insufficiency.

Thyroid and pheochromocytoma

Abrupt withdrawal in thyrotoxicosis may trigger a thyroid storm, and in pheochromocytoma alpha-adrenergic blockade must be established before metoprolol is started.

See Interactions for the full list of drug combinations.

Dosage

Toprol-XL Products
FormulationActive IngredientsClinical Note
Extended-release tabletsToprol-XL25, 50, 100, 200 mg (scored)
Hypertension — adultsToprol-XL25–100 mg once daily; titrate weekly; above 400 mg not studied
Hypertension — children 6+Toprol-XL1 mg/kg once daily (max 50 mg start); above 2 mg/kg not studied
AnginaToprol-XL100 mg once daily; titrate weekly
Heart failureToprol-XL25 mg (class II) or 12.5 mg (more severe); double every 2 weeks to 200 mg
Liver impairmentToprol-XLStart low and increase gradually
Kidney impairmentToprol-XLNo specific adjustment in the labelling

Source: 1

Exceeding the dose
Overdose can cause severe slow heart rate, low blood pressure, cardiogenic shock, heart block, heart failure, bronchospasm and impaired consciousness; it may resist treatment with adrenergic drugs, and haemodialysis is unlikely to help.1

Marketed strengths and their labelers are listed in the FDA National Drug Code Directory.6

What Does Toprol-XL Interact With?

Interactions by Severity
Interacting SubstanceEffect and RiskSeverityDocumentation
Strong CYP2D6 inhibitors (quinidine, fluoxetine, paroxetine, propafenone)Metoprolol levels doubled; less cardioselectivityMajorGood — labelled
Reserpine, MAO inhibitorsHypotension, marked bradycardiaModerateGood — labelled
ClonidineWorse rebound hypertension on withdrawalMajorGood — labelled
Digitalis, diltiazem, verapamilIncreased risk of slow heart rateMajorGood — labelled
Epinephrine (for allergy)Reduced responseMajorGood — labelled

Source: 1

Toprol-XL is extended-release metoprolol succinate taken once daily; Lopressor is immediate-release metoprolol tartrate.
Yes. The scored tablets can be halved, but should not be crushed or chewed.
In heart failure with reduced ejection fraction, Toprol-XL reduced all-cause mortality by 34%.
At 12.5 or 25 mg once daily, doubled every two weeks as tolerated up to 200 mg.
No. It is tapered over one to two weeks.

Evidence scope

What we know
  • MERIT-HF: 34% lower all-cause mortality in heart failure.
  • Blood pressure fell by 6–8/4–7 mmHg more than placebo.
  • Scored tablets can be halved but not crushed or chewed.
  • The same total daily dose is used when switching from tartrate.
What remains uncertain
  • Effects in children under 6.
  • Whether subgroup differences in MERIT-HF reflect true effects.
  • Effects of doses above 400 mg per day, which have not been studied.

Source: 1

What has been reported to the FDA

As of the FAERS data cut of 2026-07-30, the FDA Adverse Event Reporting System held 86,194 reports naming metoprolol succinate, of which 53,933 were classed as serious; reports for metoprolol tartrate are summarised separately on the Lopressor page.

Most Reported Terms
Coded termReportsReading
Fatigue6,474Listed reaction (tiredness)
Diarrhoea5,290Listed reaction
Nausea5,020Non-specific
Dyspnoea4,932Listed reaction
Drug ineffective4,271Treatment did not work; not a safety finding
Off label use4,228Use outside approved indications
Dizziness4,213Listed reaction
Headache3,861Non-specific
Death3,539Non-specific
Asthenia3,265Non-specific

Source: 7

How to read this set

Reports are voluntary and unverified; they cannot show that metoprolol caused an event or how often it occurs.

Who was this medicine studied in?

MERIT-HF randomised 3,991 people with heart failure, a hypertension study enrolled 1,092 adults and a paediatric study 144 children.1

Who this is and is not appropriate for

Not for severe bradycardia, high-grade heart block, cardiogenic shock, decompensated heart failure or sick sinus syndrome without a pacemaker.

Adults with high blood pressure, angina or stable heart failure with reduced ejection fraction, and children aged 6 or older with high blood pressure.

Where to report and verify

Routing to Official Registries
What you needWhere to go
Report a side effectFDA MedWatch
Pregnancy-specific dataMotherToBaby
Full prescribing informationDailyMed
Verify a pharmacy websiteFDA BeSafeRx · LegitScript

References

  1. FDA Prescribing Information, TOPROL-XL (metoprolol succinate) extended-release tablets 25–200 mg (Melinta Therapeutics; NDA 019962)
    Revised 2026-03 · Accessed 2026-10-22
    Used for: indications, dosing incl. children, heart failure and switching, contraindications, warnings, adverse reactions, interactions, specific populations, overdose, MERIT-HF.
    dailymed.nlm.nih.gov — TOPROL-XL SPL
  2. Drugs@FDA
    Record accessed 2026-10-22
    Used for: application and marketing status.
    accessdata.fda.gov — Drugs@FDA
  3. FDA Orange Book
    Accessed 2026-10-22
    Used for: reference and generic listings.
    accessdata.fda.gov — Orange Book
  4. FDA — Generic Drugs: Questions & Answers
    Accessed 2026-10-22
    Used for: requirements for generic equivalence (same active ingredient, strength, bioequivalence).
    fda.gov — Generic Drugs Q&A
  5. FDA BeSafeRx — signs of a safe pharmacy website (flyer)
    Accessed 2026-10-22
    Used for: four signs of a lawful pharmacy website.
    fda.gov — BeSafeRx
  6. FDA National Drug Code Directory
    Directory accessed 2026-10-22
    Used for: marketed products and strengths.
    accessdata.fda.gov — NDC Directory
  7. FDA Adverse Event Reporting System (openFDA)
    Data cut 2026-07-30 · Accessed 2026-10-22
    Used for: report totals and the ten most frequent terms.
    open.fda.gov — drug adverse event API

How this page was sourced

Clinical, dosing and safety facts come from the current FDA prescribing information for Toprol-XL, including MERIT-HF.

Approval data come from Drugs@FDA; report counts from openFDA FAERS.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

Medicine graph

FDA-approved uses

Contraindications (FDA label)

  • Severe bradycardia: Greater than first degree heart block, or sick sinus syndrome without a pacemaker.
  • Cardiogenic shock or decompensated heart failure.
  • Known hypersensitivity to product components.

FDA labels: NDA019962 · NDA219373 · NDA017963 · NDA210428